- Germany has a population of over 82 million people with a life expectancy of 78 years for males and 83 years for females. It does not have a national health care system but instead uses several autonomous bodies.
- The top causes of death are diseases of the circulatory system like heart disease and stroke. Cancer is also a leading cause of death.
- HIV prevalence is highest among men who have sex with men, accounting for nearly half of new HIV diagnoses. Prevalence is also high among migrants from countries with generalized epidemics.
- Over 10 million people in Germany are officially recognized as disabled. The majority have a severe disability and over half are over 65 years old. Germany provides strong legal protections and social support for
This document summarizes the work of the WHO Regional Office for Europe from 2010 to 2014. It outlines the office's strategic priorities, including improving health systems, addressing noncommunicable and communicable diseases, and strengthening emergency preparedness. Key achievements are highlighted, such as increased life expectancy in Europe, declines in premature mortality from noncommunicable diseases, and higher rates of treatment for HIV/AIDS and tuberculosis. Challenges remaining include health inequities and curbing the HIV epidemic. The report emphasizes multisectoral collaboration and a life-course approach to tackle challenges and promote healthier, more equitable and sustainable societies in Europe.
Romania’s current tuberculosis (TB) problems illustrate the consequence of what happens when the challenges of such a disease are, for many years, met with lethargy rather than action. The country currently has about 1/4 of all TB cases in the EU and European Economic Area, even though it has just under 4% of the area’s total population. What are the main barriers to addressing TB in Romania? To what extent are there opportunities for change?
1) The document outlines the TB and MDR-TB burden in the WHO European Region, with 41% of cases occurring in Europe and 25% in Southeast Asia.
2) It summarizes achievements of the previous TB Action Plan from 2015, including reducing the estimated prevalence of MDR-TB cases and increasing MDR-TB detection and treatment coverage.
3) The new TB Action Plan for 2016-2020 aims to build on these achievements through full scale-up of rapid diagnosis, expanding patient-centered care models, shorter treatment regimens, preventive therapy, and intersectoral approaches to reduce inequities and progress toward a TB-free Europe.
This document provides a summary of the work of the WHO Regional Office for Europe. It discusses progress made in several areas such as:
1) Declining inequalities in life expectancy across countries in the region.
2) Strengthening of policies by European countries to reduce tobacco and alcohol consumption and increase physical activity.
3) Successful control and prevention programs reducing communicable diseases like tuberculosis, measles, and malaria.
4) Efforts to strengthen health systems, promote universal health coverage, and develop a people-centered approach to healthcare delivery.
5) Work to improve emergency preparedness, surveillance of diseases, and response capacity to health emergencies and public health threats.
Non-communicable diseases (NCDs) such as heart disease, cancer, diabetes and respiratory diseases account for the majority of deaths worldwide. Over 38 million people die from NCDs each year, with 80% of deaths occurring in low- and middle-income countries. The main risk factors that drive NCDs are tobacco use, physical inactivity, unhealthy diets and harmful use of alcohol. In response, the WHO has created a global action plan to reduce premature NCD deaths by 25% by 2025 through targeting these key risk factors. National programs are also seeking to prevent and control NCDs through lifestyle changes, early diagnosis and management.
NCD Update: Policies and Programs for the Prevention and Control of NCD's_Jef...CORE Group
NCDs such as cardiovascular disease, cancers, diabetes and chronic respiratory diseases are responsible for 63% of global deaths and are projected to increase by 15% between 2010-2020. Common risk factors include tobacco use, alcohol, poor nutrition and physical inactivity. While myths exist that NCDs are less common than infectious diseases or only affect the rich, they result in premature death and disability as well as lost productivity and high treatment costs. The UN has held meetings on NCD prevention and control, establishing a target of a 25% reduction in NCD mortality by 2025, but less than 3% of international aid goes to NCDs despite their large burden.
This document summarizes the work of the WHO Regional Office for Europe from 2010 to 2014. It outlines the office's strategic priorities, including improving health systems, addressing noncommunicable and communicable diseases, and strengthening emergency preparedness. Key achievements are highlighted, such as increased life expectancy in Europe, declines in premature mortality from noncommunicable diseases, and higher rates of treatment for HIV/AIDS and tuberculosis. Challenges remaining include health inequities and curbing the HIV epidemic. The report emphasizes multisectoral collaboration and a life-course approach to tackle challenges and promote healthier, more equitable and sustainable societies in Europe.
Romania’s current tuberculosis (TB) problems illustrate the consequence of what happens when the challenges of such a disease are, for many years, met with lethargy rather than action. The country currently has about 1/4 of all TB cases in the EU and European Economic Area, even though it has just under 4% of the area’s total population. What are the main barriers to addressing TB in Romania? To what extent are there opportunities for change?
1) The document outlines the TB and MDR-TB burden in the WHO European Region, with 41% of cases occurring in Europe and 25% in Southeast Asia.
2) It summarizes achievements of the previous TB Action Plan from 2015, including reducing the estimated prevalence of MDR-TB cases and increasing MDR-TB detection and treatment coverage.
3) The new TB Action Plan for 2016-2020 aims to build on these achievements through full scale-up of rapid diagnosis, expanding patient-centered care models, shorter treatment regimens, preventive therapy, and intersectoral approaches to reduce inequities and progress toward a TB-free Europe.
This document provides a summary of the work of the WHO Regional Office for Europe. It discusses progress made in several areas such as:
1) Declining inequalities in life expectancy across countries in the region.
2) Strengthening of policies by European countries to reduce tobacco and alcohol consumption and increase physical activity.
3) Successful control and prevention programs reducing communicable diseases like tuberculosis, measles, and malaria.
4) Efforts to strengthen health systems, promote universal health coverage, and develop a people-centered approach to healthcare delivery.
5) Work to improve emergency preparedness, surveillance of diseases, and response capacity to health emergencies and public health threats.
Non-communicable diseases (NCDs) such as heart disease, cancer, diabetes and respiratory diseases account for the majority of deaths worldwide. Over 38 million people die from NCDs each year, with 80% of deaths occurring in low- and middle-income countries. The main risk factors that drive NCDs are tobacco use, physical inactivity, unhealthy diets and harmful use of alcohol. In response, the WHO has created a global action plan to reduce premature NCD deaths by 25% by 2025 through targeting these key risk factors. National programs are also seeking to prevent and control NCDs through lifestyle changes, early diagnosis and management.
NCD Update: Policies and Programs for the Prevention and Control of NCD's_Jef...CORE Group
NCDs such as cardiovascular disease, cancers, diabetes and chronic respiratory diseases are responsible for 63% of global deaths and are projected to increase by 15% between 2010-2020. Common risk factors include tobacco use, alcohol, poor nutrition and physical inactivity. While myths exist that NCDs are less common than infectious diseases or only affect the rich, they result in premature death and disability as well as lost productivity and high treatment costs. The UN has held meetings on NCD prevention and control, establishing a target of a 25% reduction in NCD mortality by 2025, but less than 3% of international aid goes to NCDs despite their large burden.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
This document is a term paper submitted by students of the Bachelor of Public Health program at La Grande International College in Nepal on the topic of the prevalence of non-communicable diseases. It provides background information on NCDs including risk factors. Global data shows NCDs account for 60% of deaths worldwide, with 80% occurring in low- and middle-income countries. In Nepal, NCDs account for 42% of all deaths currently and are projected to cause 66.3% of deaths by 2030. The term paper analyzes NCD prevalence in Nepal and compares communicable to non-communicable disease burdens. It also examines Nepal's NCD policies and strategies.
Epidemiology of Non Communicable Diseases (NCDs)Prabesh Ghimire
Declaration: The materials incorporated in this document have come from variety of sources and compiler bears no responsibilities for any information contained herein. The compiler acknowledges all the sources although references have not been explicitly cited for all the contents in this document.
Non-communicable diseases (NCDs) are a misnomer as some are caused by infectious agents, some may be cured, and some are not chronic. NCDs have shifted from being problems of wealthy nations to a global pandemic. They currently cause 36 million premature deaths annually and that number is projected to rise to 55 million by 2030. The main causes of mortality worldwide are cardiovascular diseases and cancers. NCDs present a growing public health challenge due to increased life expectancy, environmental risks, economic issues like poverty and food insecurity, rapid technology development, antibiotic resistance, and competition for global resources. A multi-level public health approach is needed involving prevention, surveillance, and treatment of NCDs.
Role of peripheral health centres in non communicable diseasesSHAFI UR RAHMAN KHAN
This document discusses the role of peripheral health centers in managing non-communicable diseases (NCDs) in India. It notes that NCDs account for over 60% of deaths globally and are a major cause of mortality in India as well. It then outlines the roles of sub-centers and primary health centers (PHCs) in promoting healthy behaviors, opportunistically screening for NCDs, diagnosing and managing cases, collecting data, and referring more advanced cases. PHCs establish NCD clinics to provide clinical services, investigations, and counseling. The role of community health centers is also described, including expanded screening, prevention activities, lab tests, diagnosis, referral networks, data collection, and hiring dedicated staff.
The document is a letter from the editor of RGA's medical underwriting newsletter, ReFlections. It introduces the articles in the latest edition, including ones on trends in pulmonary diseases by Dr. Sheetal Salgaonkar and the increasing relevance of biomarkers for underwriters by Hilary Henly. The editor notes this will be their last issue, as they are retiring after 15 years of editing the newsletter. They are confident the new editor, Dr. Philip Smalley, will continue providing thoughtful articles from RGA associates.
- In 2009, there were an estimated 9.4 million new cases of tuberculosis (TB) globally and 1.7 million deaths from the disease. TB disproportionately impacts young adults in developing countries.
- Progress has been made in detecting and treating cases. However, multidrug-resistant TB (MDR-TB) poses a growing challenge, with an estimated 440,000 new cases in 2008.
- Meeting the 2015 targets for reducing TB incidence and deaths will require intensified efforts to expand diagnosis and treatment, particularly for vulnerable groups like people living with HIV. Sustained funding of global TB programs is also needed.
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
This document provides a summary of the 2009 AIDS epidemic update published by UNAIDS and the WHO. It finds that the number of people living with HIV globally continues to rise and reached 33.4 million in 2008. An estimated 2.7 million new HIV infections and 2 million AIDS-related deaths occurred in 2008. While the epidemic has stabilized in most regions, prevalence continues to rise in Eastern Europe and Central Asia and parts of Asia. Sub-Saharan Africa remains most heavily affected, accounting for 71% of new infections globally in 2008. The report examines trends by region and finds evidence of successes in HIV prevention in some countries.
This document summarizes a study on the impact of gender role conflict and Black racial identification on sexual risk behavior among Black men who have sex with men (MSM) in the United States. The study surveyed 480 Black MSM in Atlanta, Georgia about their sexual behaviors and administered questionnaires measuring gender role conflict and Black racial identity. The results showed higher rates of unprotected anal intercourse compared to unprotected vaginal intercourse. Having more than 7 sexual partners in the past year and recruiting from certain venues predicted greater sexual risk. Higher gender role conflict and private racial regard predicted riskier behaviors with female partners.
Global Commission on HIV and the Law: Risks, Rights and HealthUNDP Eurasia
The document summarizes the findings and recommendations of the Global Commission on HIV and the Law regarding the criminalization of HIV transmission, exposure, and non-disclosure. The Commission found that criminal laws are not an effective HIV prevention tool, criminalize marginalized groups disproportionately, and violate human rights. The Commission recommends countries repeal laws criminalizing HIV, only pursue cases of intentional transmission under general criminal law, and review past convictions for exposure and non-disclosure.
- HIV and various co-infections like hepatitis B, hepatitis C, tuberculosis, and sexually transmitted infections are a concern in Germany. An estimated 60,000 people are living with HIV in Germany.
- Men who have sex with men (MSM) account for 80% of HIV cases and 70% of new HIV infections in Germany. Co-infection rates of hepatitis B, hepatitis C, and syphilis are also high among MSM.
- The German government has created an action plan for 2007-2010 to address HIV and STI prevention through expanded testing, prevention campaigns, education, and routine STI screening for at-risk groups like MSM.
This document provides an overview and comparison of major healthcare systems around the world. It begins by outlining the educational goals of identifying key healthcare models, comparing systems, and examining issues and possible solutions in the US system. The document then analyzes four main models - the Bismarck model found in Germany and others, the Beveridge model in the UK, the National Health Insurance model in Canada, and out-of-pocket systems in developing nations. It also reviews quality, access and costs of healthcare in countries like the US, UK, Canada and France.
The document discusses India's National Health Policy and the importance of having an integrated Health Management Information System (HMIS). It outlines some key goals of the National Health Policy including reducing mortality from diseases like tuberculosis and malaria. It also identifies gaps in how health data is currently collected and used, noting that data is often incomplete, unreliable and not used by local planners. It argues that reforming the health information system to make it simpler and more valuable to frontline health workers could help improve service coverage and quality.
This document discusses several key concepts related to health policy:
1. It identifies prerequisites for health such as peace, shelter, education, food, income, and environmental sustainability.
2. It outlines five areas for building healthy public policy: building healthy environments, strengthening communities, developing personal skills, reorienting healthcare services, and advocating for these changes.
3. It discusses prevention strategies starting from changing social and environmental risk factors and continuing support for at-risk groups. Prevention strategies are amenable to policy changes.
This document provides information about HIV/AIDS, including:
- It defines endemic, epidemic, and pandemic, with AIDS classified as a pandemic.
- As of 2003, it was estimated that 40 million people worldwide were living with HIV/AIDS, with 25-28.2 million in Sub-Saharan Africa.
- HIV attacks and destroys CD4 cells, weakening the immune system and leaving the body vulnerable to opportunistic infections over time without treatment.
- HIV is transmitted through direct contact with infected bodily fluids like blood, semen, vaginal fluids. It cannot be transmitted by casual contact.
- Prevention strategies include blood screening, education on safer sex practices, STI treatment, and preventing mother
This document summarizes social diseases and health issues in Germany. It discusses the prevalence of various cancers and respiratory illnesses in different regions, often linked to adverse environmental or occupational conditions. Mining regions in particular experience high rates of lung diseases. It also outlines trends in cardiovascular disease mortality and risk factors. Germany has a concentrated HIV epidemic, with the majority of cases occurring among men who have sex with men. Overall health spending accounts for around 15% of Germany's national income and the system employs over 2 million workers in outpatient care.
MDR-TB continues to ravage Europe, making it the most affected region globally. Only 50% of MDR-TB patients are detected and half of those successfully treated. This calls for increased access to new TB drugs, faster diagnosis, and patient-centered care as advocated in the new End TB Strategy and European action plan. While TB rates are declining in Europe, nearly 1,000 new cases still occur daily, with high burdens in 18 priority countries where 84% of cases and 90% of deaths occur. MDR rates remain high, underscoring the need for better detection and treatment in Europe.
There is a growing body of evidence indicating an increased burden of HIV among older adults. We describe the socio-demographic profile of adults aged 50 years and
over that are newly diagnosed with HIV in the European Union/European Economic Area (EU/EEA), to inform HIV testing and prevention efforts.
Poster at EACS 2015.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
This document is a term paper submitted by students of the Bachelor of Public Health program at La Grande International College in Nepal on the topic of the prevalence of non-communicable diseases. It provides background information on NCDs including risk factors. Global data shows NCDs account for 60% of deaths worldwide, with 80% occurring in low- and middle-income countries. In Nepal, NCDs account for 42% of all deaths currently and are projected to cause 66.3% of deaths by 2030. The term paper analyzes NCD prevalence in Nepal and compares communicable to non-communicable disease burdens. It also examines Nepal's NCD policies and strategies.
Epidemiology of Non Communicable Diseases (NCDs)Prabesh Ghimire
Declaration: The materials incorporated in this document have come from variety of sources and compiler bears no responsibilities for any information contained herein. The compiler acknowledges all the sources although references have not been explicitly cited for all the contents in this document.
Non-communicable diseases (NCDs) are a misnomer as some are caused by infectious agents, some may be cured, and some are not chronic. NCDs have shifted from being problems of wealthy nations to a global pandemic. They currently cause 36 million premature deaths annually and that number is projected to rise to 55 million by 2030. The main causes of mortality worldwide are cardiovascular diseases and cancers. NCDs present a growing public health challenge due to increased life expectancy, environmental risks, economic issues like poverty and food insecurity, rapid technology development, antibiotic resistance, and competition for global resources. A multi-level public health approach is needed involving prevention, surveillance, and treatment of NCDs.
Role of peripheral health centres in non communicable diseasesSHAFI UR RAHMAN KHAN
This document discusses the role of peripheral health centers in managing non-communicable diseases (NCDs) in India. It notes that NCDs account for over 60% of deaths globally and are a major cause of mortality in India as well. It then outlines the roles of sub-centers and primary health centers (PHCs) in promoting healthy behaviors, opportunistically screening for NCDs, diagnosing and managing cases, collecting data, and referring more advanced cases. PHCs establish NCD clinics to provide clinical services, investigations, and counseling. The role of community health centers is also described, including expanded screening, prevention activities, lab tests, diagnosis, referral networks, data collection, and hiring dedicated staff.
The document is a letter from the editor of RGA's medical underwriting newsletter, ReFlections. It introduces the articles in the latest edition, including ones on trends in pulmonary diseases by Dr. Sheetal Salgaonkar and the increasing relevance of biomarkers for underwriters by Hilary Henly. The editor notes this will be their last issue, as they are retiring after 15 years of editing the newsletter. They are confident the new editor, Dr. Philip Smalley, will continue providing thoughtful articles from RGA associates.
- In 2009, there were an estimated 9.4 million new cases of tuberculosis (TB) globally and 1.7 million deaths from the disease. TB disproportionately impacts young adults in developing countries.
- Progress has been made in detecting and treating cases. However, multidrug-resistant TB (MDR-TB) poses a growing challenge, with an estimated 440,000 new cases in 2008.
- Meeting the 2015 targets for reducing TB incidence and deaths will require intensified efforts to expand diagnosis and treatment, particularly for vulnerable groups like people living with HIV. Sustained funding of global TB programs is also needed.
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
This document provides a summary of the 2009 AIDS epidemic update published by UNAIDS and the WHO. It finds that the number of people living with HIV globally continues to rise and reached 33.4 million in 2008. An estimated 2.7 million new HIV infections and 2 million AIDS-related deaths occurred in 2008. While the epidemic has stabilized in most regions, prevalence continues to rise in Eastern Europe and Central Asia and parts of Asia. Sub-Saharan Africa remains most heavily affected, accounting for 71% of new infections globally in 2008. The report examines trends by region and finds evidence of successes in HIV prevention in some countries.
This document summarizes a study on the impact of gender role conflict and Black racial identification on sexual risk behavior among Black men who have sex with men (MSM) in the United States. The study surveyed 480 Black MSM in Atlanta, Georgia about their sexual behaviors and administered questionnaires measuring gender role conflict and Black racial identity. The results showed higher rates of unprotected anal intercourse compared to unprotected vaginal intercourse. Having more than 7 sexual partners in the past year and recruiting from certain venues predicted greater sexual risk. Higher gender role conflict and private racial regard predicted riskier behaviors with female partners.
Global Commission on HIV and the Law: Risks, Rights and HealthUNDP Eurasia
The document summarizes the findings and recommendations of the Global Commission on HIV and the Law regarding the criminalization of HIV transmission, exposure, and non-disclosure. The Commission found that criminal laws are not an effective HIV prevention tool, criminalize marginalized groups disproportionately, and violate human rights. The Commission recommends countries repeal laws criminalizing HIV, only pursue cases of intentional transmission under general criminal law, and review past convictions for exposure and non-disclosure.
- HIV and various co-infections like hepatitis B, hepatitis C, tuberculosis, and sexually transmitted infections are a concern in Germany. An estimated 60,000 people are living with HIV in Germany.
- Men who have sex with men (MSM) account for 80% of HIV cases and 70% of new HIV infections in Germany. Co-infection rates of hepatitis B, hepatitis C, and syphilis are also high among MSM.
- The German government has created an action plan for 2007-2010 to address HIV and STI prevention through expanded testing, prevention campaigns, education, and routine STI screening for at-risk groups like MSM.
This document provides an overview and comparison of major healthcare systems around the world. It begins by outlining the educational goals of identifying key healthcare models, comparing systems, and examining issues and possible solutions in the US system. The document then analyzes four main models - the Bismarck model found in Germany and others, the Beveridge model in the UK, the National Health Insurance model in Canada, and out-of-pocket systems in developing nations. It also reviews quality, access and costs of healthcare in countries like the US, UK, Canada and France.
The document discusses India's National Health Policy and the importance of having an integrated Health Management Information System (HMIS). It outlines some key goals of the National Health Policy including reducing mortality from diseases like tuberculosis and malaria. It also identifies gaps in how health data is currently collected and used, noting that data is often incomplete, unreliable and not used by local planners. It argues that reforming the health information system to make it simpler and more valuable to frontline health workers could help improve service coverage and quality.
This document discusses several key concepts related to health policy:
1. It identifies prerequisites for health such as peace, shelter, education, food, income, and environmental sustainability.
2. It outlines five areas for building healthy public policy: building healthy environments, strengthening communities, developing personal skills, reorienting healthcare services, and advocating for these changes.
3. It discusses prevention strategies starting from changing social and environmental risk factors and continuing support for at-risk groups. Prevention strategies are amenable to policy changes.
This document provides information about HIV/AIDS, including:
- It defines endemic, epidemic, and pandemic, with AIDS classified as a pandemic.
- As of 2003, it was estimated that 40 million people worldwide were living with HIV/AIDS, with 25-28.2 million in Sub-Saharan Africa.
- HIV attacks and destroys CD4 cells, weakening the immune system and leaving the body vulnerable to opportunistic infections over time without treatment.
- HIV is transmitted through direct contact with infected bodily fluids like blood, semen, vaginal fluids. It cannot be transmitted by casual contact.
- Prevention strategies include blood screening, education on safer sex practices, STI treatment, and preventing mother
This document summarizes social diseases and health issues in Germany. It discusses the prevalence of various cancers and respiratory illnesses in different regions, often linked to adverse environmental or occupational conditions. Mining regions in particular experience high rates of lung diseases. It also outlines trends in cardiovascular disease mortality and risk factors. Germany has a concentrated HIV epidemic, with the majority of cases occurring among men who have sex with men. Overall health spending accounts for around 15% of Germany's national income and the system employs over 2 million workers in outpatient care.
MDR-TB continues to ravage Europe, making it the most affected region globally. Only 50% of MDR-TB patients are detected and half of those successfully treated. This calls for increased access to new TB drugs, faster diagnosis, and patient-centered care as advocated in the new End TB Strategy and European action plan. While TB rates are declining in Europe, nearly 1,000 new cases still occur daily, with high burdens in 18 priority countries where 84% of cases and 90% of deaths occur. MDR rates remain high, underscoring the need for better detection and treatment in Europe.
There is a growing body of evidence indicating an increased burden of HIV among older adults. We describe the socio-demographic profile of adults aged 50 years and
over that are newly diagnosed with HIV in the European Union/European Economic Area (EU/EEA), to inform HIV testing and prevention efforts.
Poster at EACS 2015.
The document summarizes a WHO policy framework called Health 2020 that aims to significantly improve population health and well-being in Europe and reduce health inequities. It discusses challenges like uneven health improvements between countries and rising noncommunicable diseases. Health 2020 was developed based on extensive evidence and stakeholder input to promote integrated, upstream approaches addressing social determinants of health through multisectoral collaboration.
AIDS is a disease of the human immune system caused by the HIV virus. It is a major global health problem that is spreading widely. HIV is transmitted through sexual contact, contaminated blood transfusions, and shared hypodermic needles. From 1986 to 2010, AIDS killed over 12,000 people in Malaysia, most of them men. Highly active antiretroviral therapy has improved life expectancy for those infected with HIV, but many still lack access to testing, treatment, and care. The financial costs of HIV treatment are also significant.
The document summarizes a seminar presentation on HIV/AIDS. It provides background on HIV/AIDS, including how it attacks the immune system. It discusses the global and national epidemiology of HIV/AIDS, highlighting trends in prevalence. It presents the epidemiological triad of HIV/AIDS, including the agent (HIV virus), reservoir of infection (humans), and factors influencing transmission. It states the objectives of the seminar were to explore the epidemiology, review milestones and current policies/strategies in Nepal, and discuss prevention and control methods.
The document outlines a seminar presentation on HIV/AIDS given by Group B. It includes an introduction, background on HIV/AIDS, the epidemiological triad, risk factors, the current situation in Nepal, objectives, methodology, findings, and recommendations for prevention and control. The group discussed the stages of HIV infection, transmission methods, symptoms, complications, and strategies like education, condom promotion, and treatment.
This document provides an overview of Acquired Immunodeficiency Syndrome (AIDS) and the Human Immunodeficiency Virus (HIV) that causes it. It discusses how HIV breaks down the immune system, leaving those infected vulnerable to life-threatening infections. The document outlines the history of the HIV epidemic and how it has affected both developed and developing countries. It also summarizes HIV transmission routes, clinical stages of infection from initial exposure to AIDS, diagnostic testing approaches, treatment options including antiretroviral drugs, prevention strategies, and healthcare follow-up for those living with HIV/AIDS.
1. The WHO Regional Director for Europe launched the Knowledge Hub on Health and Migration, a multi-stakeholder platform for sharing knowledge and improving public policies around health needs of migrants.
2. An analysis of health indicators in Sicily found higher infant mortality, lower life expectancy, and social inequalities compared to other EU regions in Italy.
3. Reducing health inequities will require action on social, economic, and environmental determinants of health across the life course from early childhood through working years.
Global tuberculosis rates have declined significantly since 1990. 56 million patients have been successfully treated and 22 million lives have been saved since 1995. The TB mortality rate has declined 45% globally since 1990. However, TB remains one of the top three killers of women worldwide. In 2012, there were an estimated 530,000 TB cases among children and 74,000 TB deaths among HIV-negative children. Treatment success rates have improved dramatically from 69% in 2000 to 87% in 2011. Despite progress, many TB cases are still being missed due to lack of diagnosis. In 2012, only 66% of the estimated 8.6 million incident TB cases were detected and notified. Multidrug-resistant TB also remains a major public health crisis,
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
This document discusses four major non-communicable diseases: cancer, diabetes, cardiovascular diseases, and chronic respiratory diseases. It defines non-communicable diseases as conditions that are not passed from person to person but rather are caused by multiple factors like lifestyle and environment. For each disease, it provides facts, risk factors, prevention methods, and treatment approaches. The main points are that tobacco use, unhealthy diet, physical inactivity, and air pollution are major risk factors, and that controlling these through prevention programs and medical treatment could significantly reduce mortality from non-communicable diseases.
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxanjalatchi
The document discusses World Tuberculosis Day which occurs on March 24th each year. It notes that the 2021 theme is "The Clock is Ticking" to convey the urgency of acting to end TB. Some key facts about TB are provided, such as that 1.4 million people died from the disease in 2019, 10 million fell ill worldwide, and the 30 highest burden countries account for 87% of new cases. The document outlines definitions, causes, symptoms, diagnosis and treatment of TB as well as prevention strategies and challenges in eliminating the disease by 2030.
TB/HIV co-infections have risen sharply across Europe between 2011-2015, threatening progress made in reducing TB cases. While TB deaths and cases have decreased and treatment success has increased for most groups, TB/HIV deaths and cases are rising significantly. Drug-resistant TB also remains a major problem, with over half of cases in Europe being multi-drug resistant and about a quarter being extensively drug resistant. Increased efforts are needed across Europe to curb the rise of TB/HIV and improve diagnosis and treatment of drug resistant TB.
1) The WHO European Region has seen increasing migration, with over 90 million international migrants in 2017 accounting for 10% of the population. Migrants make up a large portion of the labor force.
2) Migrant and refugee populations face higher risks for certain communicable diseases like HIV and tuberculosis. They also experience higher rates of mental health issues and poorer maternal and child health outcomes.
3) In response, WHO/Europe has established innovative programs in countries like Italy and Turkey to advocate for migrant health, develop policies, provide health information and training, and give technical assistance. They are also working on a global framework to promote refugee and migrant health worldwide.
This document discusses emerging infectious diseases and antimicrobial resistance as key issues for health governance in Europe. It provides information on progress made in several areas:
1) Establishing a WHO European action plan to address antimicrobial resistance that has been adopted by all 53 member states.
2) Expanding infectious disease surveillance networks to cover all member states.
3) Collecting region-wide data on antimicrobial use and consumption to support action by countries.
4) Adopting strategies in the European action plan for HIV/AIDS from 2012-2015 to reduce vulnerability and optimize prevention and treatment outcomes.
The document summarizes key points from a presentation on developing a Model of Care to address tuberculosis (TB) in London. It outlines three main aspects the model aims to improve: 1) detection and diagnosis of TB through raising awareness in high-risk communities and among healthcare workers, and piloting active/latent case finding; 2) coordinated commissioning of TB services; and 3) reducing variability in service provision across London. The model was developed through extensive stakeholder engagement to address increasing TB rates in London and risks of further fragmentation, unequal care, and drug-resistant TB without changes to the current system.
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO SEJOJO PHAAROE
Chronic non infectious diseases that are silent and persecute mankind . non-communicable disease (NCD) is a disease that is not transmissible directly from one person to another. NCDs include Parkinson's disease, autoimmune diseases, strokes, heart diseases, cancers, diabetes, chronic kidney disease, osteoarthritis, osteoporosis, Alzheimer's disease, cataracts, and other
Infectious disease control as part of prevention of cancer in developing coun...Jean Jacques Bernatas
1. Several cancers are caused by infectious agents, particularly viruses like HPV, Hepatitis B and C, and HIV.
2. Prevention of infection-related cancers involves preventing contact with pathogens, immunization against pathogens, and treating infections to prevent cancer development.
3. Many prevention measures can be implemented in low-resource settings through improved healthcare access, financing, education, and training of healthcare workers.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
2. Deutschland
• Germany is a densely populated and highly industrialized country
with more than 82 million inhabitants. The life expectancy at birth is
77.6 years for males and 82.8 years for females. The percentage of
the population aged 65 years or more is rising. Germany does not
have a national health care system. The health care system is
administered through several autonomous bodies and associations
such as the statutory health insurance system (GKV), the
association of physicians under contract with the GKV, and the
hospitals association.
3.
4. Indicators Values
POPULATION 82,727,000
% of population aged 0–14 years 13
% of population aged 65+ years 21
Crude death rate per 1000 population 11
Estimated infant mortality per 1000 live births (world health report) 3
Estimated life expectancy (world health report) 81
Life expectancy at birth (years), females 83
Life expectancy at birth (years), males 78
Hospital beds per 100 000 828
Physicians per 100 000 405
5. Indicators Values
SDR all causes, all ages, per 100 000 564
SDR, diseases of circulatory system, all ages, per 100 000 200
SDR, external causes of injury and poisoning, all ages, per 100 000 28
SDR, malignant neoplasms, all ages, per 100 000 157
Total health expenditure as % of GDP, WHO estimates 11
Total expenditure on health per capita 4812
All the details mentioned above are the extracts from a survey taken by Robert Koch Institute(RKI) in
2014
6.
7. TOP 10 CAUSES OF DEATH
per 10000 population
• Disease rate global rank
• Coronary Heart Disease 62.93 133
• Lung Cancers 27.78 30
• Stroke 27.32 163
• Breast Cancer 21.84 32
• Prostate Cancer 15.98 93
10. Social Diseases
• What is a Social Disease?
• A disease having it’s highest incidence among socioeconomic group
of a country predisposed to it by a given set of adverse
living or working conditions
• Example:Prevalance of cancers and radiation related adverse
effects in regions near Chernobyl and Fukushima
• Simply it refers to regional diseases provoked by adverse
conditions.
11. PREVALENCE OF HIV IN GERMANY
• Diagnoses of new HIV infections in Germany rose by 20% in the first half of 2014
compared with the first half of 2010, according to the latest figures from the Robert
Koch Institute, Germany's centre for public health and disease control. Gay and
bisexual men accounted for almost 60% of these new HIV diagnoses, a 30% rise from
four years ago.
• With a population of 82.5 million, Germany is Europe's most populous nation.
Historically, HIV prevention has been relatively successful and new HIV diagnoses
have tended to total under 2,000 each year for the past decade. Even though in
2014 new HIV diagnoses totalled 2,058 - the highest since 2002 - this compares with
7,000 new HIV diagnoses in 2003 in the United Kingdom, the third most populous
country in Europe with around 60 million inhabitants
12.
13. • The Institute also reports on the cities with the highest HIV incidence
rates between July 2004 and June 2005. Cologne, with an incidence
rate of 12.42 per 100,000 population had the highest rate. However, the
highest absolute numbers were seen in Germany's two biggest cities,
Berlin and Hamburg, which had incidence rates of 10 per 100,000 and
9.57 per 100,000, respectively. Other cities with high HIV incidence
included Munich, Frankfurt and Düsseldorf.
14. • According to the latest estimate, there were a total of 436,500 new cancer
cases in Germany in 2004. The most common cancer in men is prostate cancer
with over 58,000 new cases per annum, followed by colorectal and lung cancer.
In women, breast cancer remains the most common cancer with an estimated
57,000 new cases every year, also followed by colorectal cancer. These and
further findings on selected cancer sites can be found in the current brochure
on "Cancer in Germany“ which is regularly published by rki.
• In addition, the RKI made cancer-prevalence estimates and calculated current
morbidity and mortality risks at the federal level for the first time
• According to these figures, the 5-year partial prevalence - i.e. the total
number of cancer patients diagnosed over the past five years who are currently
still living - exceeds 600,000 in men; the figure is about the same among
women.
Prevalence of Cancers in Germany
15.
16. • Here, too, the most common cancers are prostate cancer in men and breast
cancer in women. The lifetime risk of developing cancer, which is more related
to the individual, is estimated to be higher among men (48.5%) than among
women (40.3%)
• In roughly rounded figures, therefore, about every day, a person in Germany
develops cancer in the course of their lives
• One in four men and one in five women die of cancer.
17.
18. • In Germany, crude death rates from cancer were in excess of 300
deaths per 100 000 inhabitants in the regions of Sachsen-Anhalt,
Chemnitz, Saarland, Mecklenburg-Vorpommern, Arnsberg and
Düsseldorf
• By contrast, a relatively low crude death rate was recorded in the
southern German region of Tübingen (220 deaths per 100 000
inhabitants).
• Across the EU Member States, there was a large cluster of
relatively high death rates from breast cancer in the centre of the
EU covering much of Germany, Denmark, the Benelux countries,
eastern France, northern Italy, eastern Austria and western
Hungary; high rates were also recorded in some parts of the
United Kingdom.
19. • The HIV epidemic in Germany can be characterized as a concentrated
epidemic. The most affected population groups are
• MSM (estimated number of MSM living with HIV by the end of 2011:
46,500)
• Migrants originating from HIV high prevalence countries (estimated
number of migrants living with HIV by end of 2011: 9,000)
• IDU (estimated number of IDU living with HIV by end of 2011: 6,800
[including former IDU])
HIV INFECTION
20. Men 59000
Women 14000
Among these: Children 200
……by mode of transmission
Homosexual contact 46500
Heterosexual contact 10500
IV drug use 6500
Blood transfusion 450
Mother to Children 420
Persons living with HIV 73000
21. • Currently, the incidence is highest among MSM. It is estimated that
74 % of the HIV infections acquired in Germany are through male
homosexual contact, 20% through heterosexual contact, 6%
associated with injecting drug use. Less than 1% of infections are
due to mother-to-child transmission.
• The number of newly diagnosed HIV infections in IDU in Germany
has been continuously declining since 1997.
• Data modelling suggests that HIV incidence among MSM started to
decline as early as 2007. HIV prevalence among this group is
estimated between 5.0% and 7.5%
• Approximately half of the heterosexually acquired HIV infections
in Germany are reported in migrants originating from high
prevalence countries with a generalized epidemic (predominantly
from countries in western Sub-Saharan Africa)
22.
23. • Over the past 50 years, the reduction of mortality from CVD in
Germany has followed a similar trend as the OECD average,
reaching 310 per 100 000 population, 4% higher than the OECD
average of 299 in 2011
• the number of patients with end-stage kidney failure (ESKF),
often caused by diabetes and hypertension, at 87 per 100 000
population in 2000, is also lower than the OECD average of 101 in
2011
CARDIOVASCULAR DISEASES
24.
25. • The rate of smoking, one of the risk factors for CVD, was 21.9% for
adults in 2011, higher than the OECD average of 20.9%, and youth
smoking was 22.4%, compared to an OECD average of 19.5%, but the
most recent national data show improvements (20.9% and 18.5%
respectively in 2013).
• The rate of overweight, at 36.7%, is also higher than the OECD
average of 34.6%. On the other hand, the rate of obesity, at 14.7%, is
much lower than the OECD averages of 18.0% but it is increasing
(15.7% in 2013).
• The reported prevalence of high cholesterol levels and high blood
pressure is 24.6% and 26.0% each, again higher than the OECD
average of 18.0% and 25.6%, respectively.
• Spending on prevention, however, is 3.4% of the current health
expenditure and higher than the OECD average of 2.9%.
26. DISABLED PERSONS IN GERMANY
• In 2013, 10.2 million people with an officially recognised disability - on
the basis of microcensus results - were living in Germany
• On average, more than one in eight inhabitants (13%) was disabled
• More than half of them (52%) were men.
• The majority, that is, roughly 7.5 million people were severely
disabled, while 2.7 million people suffered from a moderate disability
27. Severely disabled people (in 2013) 7,548,965
Men 51.0%
Women 49%
>65 Years 53.4%
Age groups Disability rate
1-20 years of age 8%
20-30 6%
30-45 15%
45-65 6.8%
>65 25%
28. Overview of the facilities, organizations and support
available for people with disabilities in Germany...
• German law (Grundgesetz) forbids discrimination on the basis of physical or mental
disability.
• The Social Welfare Code IX (SGBIX), which came in to force in April 2001, is based
on the idea of equal opportunities and participation rather than merely welfare
• It focuses on rehabilitation and access for disabled people and stipulates levels of
support depending on measurement of the degree of disability
29. • According to the German Federal Statistical Office, or Destatis,
the impact of the disability on the participation in the life of
society is graded from 20 to 100.
• People are classified as severely disabled in Germany if a pension
office has determined a degree of disablement of 50 or more.
• As easily disabled persons are referred to with a degree of
disability of less than 50.
30. There is a great deal of support available to disabled people
(behinderter Menschen) in Germany, from general counselling to
specific institutions such as:
• Advice centres
• Early support centres for children (Frühförderung)
• Integrated kindergartens
• Special kindergartens (Sonderkindergarten or Förderkindergarten)
• Special Schools (Sonderschulen)
• Special professional schools (Berufsschulen), for instance for deaf pupils
31. • Apprenticeships for visually impaired and deaf people
(Ausbildungsplaetze)
• Employment integration support
• Care and accommodation grants for disabled people
• Workshops for disabled people (Werkstätten für behinderte
Menschen)
• Transport services (Fahrdienste)
32. To conclude……
• Approximately 15% of the NATION’S INCOME is used for HEALTH CARE
MANAGENMENT every year
• At present around 2.2 million people are employed in outpatient care
• In Germany, there are currently more than 200 inpatient hospices, more than
250 palliative units in hospitals and around 1,500 outpatient hospice services
• In 2013 health expenses amounted to EUR 314.9 billion. The largest item is made
up of medical followed by care services
• In an international comparison Germany ranges with per capita expenses of
around EUR 3,800 per year for health in the LIST OF EUROPEAN NATIONS Health
care is one of the industries with the highest sales revenues in Germany. 6.1
million employees worked in the health economy (including wellness, fitness
etc.) in 2012
33. References:
• Germany’s health profile -http://www.worldlifeexpectancy.com/country-health-
profile/Germany
• Causes of deaths in Germany-
https://www.destatis.de/EN/FactsFigures/SocietyState/Health/CausesDeath/Causes
Death.html
• Prevalence of various diseases in Germany-
http://www.healthdatanavigator.eu/national/Germany
• People with disabilities in Germany-https://www.angloinfo.com/germany/how-
to/germany-healthcare-people-with-disabilities
• http://www.bmas.de/EN/Our-Topics/Participation-of-Persons-with-
Disabilities/disability-policy.html
• Robert Koch Institute-
http://www.rki.de/EN/Content/Health_Monitoring/health_monitoring_node.html
Editor's Notes
MSM-Men having sexual intercourse with Men
IDU-Intravenous Drug Users
Epidemic-is the slow spread of infectious disease to a large number of people in a given population within a short period of time, usually two weeks or less
An epidemic in which HIV or another pathogen represents > 5% in any sub-population at higher risk of infection—e.g., druginjectors, sex workers, homosexual men-Concentrated epidemic
OECD-Organisation for Economic Co-operation and Developement